Startups
Participate in a Clinical Trial Vial helps you find and participate in conveniently located clinical dermatology trials at no cost. Find a Trial Vial helps you find and participate in conveniently located clinical dermatology trials at no cost. I signed up for a trial because it was a chance to get treatment and help other … Mainpage Read More »
Overview
Location
United States, California, San Francisco
Founded date
2020
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 16, 2021 | Vaccine vial maker Stevanato valued at over $5 billion in tepid NYSE debut | By Echo Wang and Sohini Podder (Reuters) -Italy's Stevanato Group S.p.A. made a tepid debut on the New York Stock Exchange as its shares slid, giving the world's second largest glass vial maker a valuation of $5 billion. Stevanato's shares ... |
| Jul 16, 2021 | Vaccine vial maker Stevanato raises $672 million in U.S. IPO | |
| Jul 16, 2021 | Vaccine vial maker Stevanato raises $672 million in U.S. IPO | Stevanato said in a statement it priced 32 million shares at $21 per share, compared to its previous plan of 40 million shares at indicated price range of $21 to $24. The IPO values Stevanato at $6.3 billion. Founded by billionaire Sergio S... |
| Jul 16, 2021 | Vaccine vial maker Stevanato valued at over $5 bln in tepid NYSE debut | July 16 (Reuters) - Italy's Stevanato Group S.p.A. made a tepid debut on the New York Stock Exchange as its shares slid, giving the world's second largest glass vial maker a valuation of $5 billion. Stevanato's shares fell more than 20% to ... |
| Jul 7, 2021 | COVID-19 vaccine vial maker Stevanato eyes $7 billion valuation in U.S. IPO | (Reuters) -Italy's Stevanato Group S.p.A., a maker of glass vials for COVID-19 vaccine and other healthcare products, said on Wednesday it was seeking a valuation of over $7 billion in its U.S. initial public offering (IPO). Founded by bill... |
| Nov 5, 2020 | Schott Kaisha to invest Rs 105 cr to expand vial production capacity | Pharma packaging firm Schott Kaisha on Thursday said it is investing Rs 105 crore in its existing facilities to increase vial production by 30 crore pieces. The decision comes at a time when drug manufacturers around the world are undertaki... |
Reviews 0
FAQ about Vial
When was Vial founded?
Vial was founded in 2020.
What has the press written about Vial?
Parsers VC has collected 7 articles mentioning Vial, among them “Vaccine vial maker Stevanato valued at over $5 billion in tepid NYSE debut” (Jul 16, 2021) and “Vaccine vial maker Stevanato raises $672 million in U.S. IPO” (Jul 16, 2021).
Is Vial still active?
Yes, Vial is active; its latest activity on Parsers VC dates from Jul 16, 2021.